Issue Type: Abuses of Government Programs and Regulations
In challenge narrative 12/9/20
-
Xeljanz, the FDA, and nine years of patient harm
-
Atypical antipsychotics: Decades of use, unfathomable harms
-
What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs
-
Medicare Must Study Unproven, Expensive Alzheimer’s Drug
-
Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle
-
CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs
-
CMS Announces Delay of MCIT Final Rule
-
Curbing Biologic Drug Spending with P-quad
-
Ethics of Clinical Trials to Evaluate Biosimilars
-
Abuses of Government Programs and Regulations